Saman Zafar

Saman Zafar practices at Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Saman Zafar's NPI, 1649654955, was assigned on July 16, 2015. Saman Zafar holds Pennsylvania license MT209870.

Saman Zafar's primary practice is Jefferson Einstein Philadelphia Hospital, at 5501 Old York Road, Philadelphia, PA 19141 in Philadelphia County. The practice phone is (215) 456-6090.

Saman Zafar's primary practice is Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Saman Zafar is also affiliated with Jefferson Einstein Montgomery Hospital. The medical group on file is Einstein Gastroenterology Associates. Dmand AI also links Saman Zafar to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Saman Zafar practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Saman Zafar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Saman Zafar is licensed in Pennsylvania.

CMS data shows 629 Medicare services from Saman Zafar across 14 procedure codes in 2024, for 326 Medicare patients. Medicare paid $60,294 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 326 Medicare patients who saw Saman Zafar in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Saman Zafar's median patient age at 62, with 58% women.

In 2024, Saman Zafar wrote 834 Medicare Part D claims for 124 patients. 87% of them were for generic drugs. CMS names the drug for 621 of them, across 23 drugs with 11 or more claims each, at $84,908 in total drug cost. In 2023, CMS named 411 claims across 16 drugs.

Saman Zafar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 32 general payments to Saman Zafar from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Merz Pharmaceuticals, LLC paid the most, $151.